Overview

An Exploratory Study in Healthy Volunteers to Identify Factors Influencing Bioequivalence Studies on Moderately Lipophilic Drugs Using Dermal Open Flow Microperfusion (dOFM)

Status:
Completed

Trial end date:
2020-07-25

Target enrollment:

Participant gender:

Summary

The overall aim of this clinical study is to develop a general bioequivalence (BE) testing method using dermal open flow microperfusion (dOFM) for dermatological drug products. In this study BE of different lidocaine/prilocaine products will be assessed and factors that influence dOFM data variability will be evaluated.

Phase:

N/A

Details

Lead Sponsor:

Joanneum Research Forschungsgesellschaft mbH

Treatments:

Lidocaine
Lidocaine, Prilocaine Drug Combination
Prilocaine